Varian Medical says its EDGE radiosurgery suite is intended for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities.
“Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining state-of-the-art linear accelerator technology with real-time tracking and patient positioning,” said Kolleen Kennedy, president of Varian’s oncology systems business, in the release. “We designed the EDGE to facilitate fast, accurate delivery of stereotactic radiosurgery to treat any condition amenable to this type of treatment, including tumors of the lung, prostate, brain, spine, and other indications throughout the body.”
The EDGE suite is currently pending FDA clearance and is not yet available for sale.
Varian Medical Systems is headquartered in Palo Alto, Calif.
Related Articles on New Technology:
SpineSmith Receives FDA Clearance for Plating System
Roche Receives FDA Clearance for Blood Glucose Monitor
Respiratory Motion Receives FDA Clearance for Respiratory Monitoring System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
